Peer-reviewedCC BY-NC-NDBlood vessels, thrombosis & hemostasis
The role of anti–factor Xa in patients with cancer receiving prophylactic low-molecular-weight heparin: a meta-analysis
- 1Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA
- 2Division of Hematology and Medical Oncology, Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA
Related
- Intracranial Hemorrhage in Patients Receiving Factor Xa Inhibitors: Challenges and Perspectives
- PO077 | BALANCING BLEEDING AND THROMBOSIS: SAFETY OF LOW-MOLECULAR-WEIGHT HEPARIN THROMBOPROPHYLAXIS IN PATIENTS WITH HEMOPHILIA UNDERGOING MAJOR SURGERY
- Relationship between transforming growth factor-β1, microRNA-29c in peritoneal dialysate and peritoneal fibrosis in patients with glomerular diseases receiving peritoneal dialysis
- Patients with cyclops syndrome exhibit elevated synovial fluid interleukin‐6 (IL‐6) and tumor necrosis factor alpha (TNF‐α) levels and disorganized collagen remodelling within the lesion: A histological and molecular study
- Bleeding events in people with hemophilia B on prophylactic factor IX treatment: a systematic review and meta-analysis.
BibTeX
@article{jang2026role,
title = {{The role of anti–factor Xa in patients with cancer receiving prophylactic low-molecular-weight heparin: a meta-analysis}},
author = {Jeffrey Jang and Dominick Zheng and Timothy Nold and Frank Deng and Daniel Park and Eugene Chao and Andrew Hwang and Charity Huang},
journal = {Blood vessels, thrombosis \& hemostasis},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657370},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - The role of anti–factor Xa in patients with cancer receiving prophylactic low-molecular-weight heparin: a meta-analysis
AU - Jeffrey Jang
AU - Dominick Zheng
AU - Timothy Nold
AU - Frank Deng
AU - Daniel Park
AU - Eugene Chao
AU - Andrew Hwang
AU - Charity Huang
PY - 2026
DA - 2026/08/27
JO - Blood vessels, thrombosis & hemostasis
UR - https://europepmc.org/article/PMC/PMC13657370
SN - 2950-3272
ER -